CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 8,851 shares at $8.28 ($73,298)
- 4 Open-market sale Chief Medical Officer sold 8,850 shares at $8.28 ($73,293)
- 4 Open-market sale PRESIDENT AND CEO sold 24,660 shares at $8.28 ($204,214)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 20,500 shares (option exercise)
- 4 Open-market sale PRESIDENT AND CEO sold 40,000 shares at $16.21 ($648,380)
- 4 Open-market sale PRESIDENT AND CEO sold 40,000 shares at an average $12.23 ($489,346)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 5,282 shares at $8.59 ($45,351)
- 4 Open-market sale Chief Financial Officer sold 5,282 shares at $8.58 ($45,338)
- 4 Open-market sale President and CEO sold 14,539 shares at $8.58 ($124,813)
- 4 Open-market sale President and CEO sold 15,664 shares at an average $8.01 ($125,499)
Page 3 of 9 · 166 filings